ArticleRheumatology and therapy2021

Baricitinib and the Risk of Incident Interstitial Lung Disease: A Descriptive Clinical Case Report from Clinical Trials.

Carlo Salvarani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.